Everence Capital Management Inc Cytokinetics Inc Transaction History

Everence Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$29.46 - $36.61 $86,612 - $107,633	-2,940 Reduced 17.87%	13,510 $398,000
Q2 2022 Jul 26, 2022	BUY	$33.93 - $48.92 $86,521 - $124,746	2,550 Added 18.35%	16,450 $646,000
Q3 2021 Oct 21, 2021	BUY	$18.54 - $35.74 $68,598 - $132,238	3,700 Added 36.27%	13,900 $497,000
Q1 2021 Apr 06, 2021	SELL	$18.57 - $25.68 $87,464 - $120,952	-4,710 Reduced 31.59%	10,200 $237,000
Q3 2020 Feb 01, 2021	SELL	$20.58 - $28.96 $30,252 - $42,571	-1,470 Reduced 8.97%	14,910 $323,000
Q1 2019 May 06, 2019	BUY	$5.95 - $10.19 $97,461 - $166,912	16,380 New	16,380 $133,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.9B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.